Perspective Therapeutics

Operator of a radiopharmaceutical company dedicated to nuclear medicine and the science of radiopharmaceutical production. The company uses SPECT (single-photon emission computerized tomography), pet (positron emission tomography) radio-pharmacies and mobile CT (computed tomography) to offer a suite of solutions addressing the challenges facing the nuclear imaging market as well as compounds and dispenses patient-specific intravenous drugs and services for use in diagnostic imaging and radiopharmaceutical therapies, thereby providing customers and patients with reliable products and services.

Developer of a drug discovery platform designed to find new points of therapeutic intervention. The company's platform integrates RNA bioinformatics, chemical biology tools, chemical and biological assays, and RNA-directed medicinal chemistry, enabling physicians to treat a range of diseases including neurology, oncology, and rare genetic diseases.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.